VTVT logo

VTv Therapeutics (VTVT) Cash From Operations

Annual CFO

-$19.08 M
-$3.06 M-19.09%

December 31, 2023

Summary

Performance

1-Year Change

-19.09%

3-Year Change

-6.01%

5-Year Change

+28.95%

15-Year Change

+57.18%

VTVT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.53%
VTVT annual cash flow from operations is higher than 47.53% of companies in Healthcare sector

High & Low

All-time High

-$16.02 M

3-Year Low

-$19.31 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VTVT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
VTVT next annual earnings announcement is scheduled for Mar 13, 2025

OtherVTVTcash flowmetrics:

Annual CFI

$4.40 M
VTVT annual cash flow from investing activities is $4.40 million

Annual CFF

$12.00 M
VTVT annual cash flow from financing activities is $12.00 million

Annual FCF

-$19.08 M
VTVT annual free cash flow is -$19.08 million

Annual CAPEX

-
VTVT annual capital expenditures value is unknown

Quarterly CFO

-$6.42 M
+$311.00 K+4.62%

September 30, 2024

Summary

Performance

3-Month Change

+4.62%

1-Year Change

+4.62%

3-Year Change

-4.07%

5-Year Change

-33.88%

VTVT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.93%
VTVT quarterly cash flow from operations is higher than 39.93% of companies in Healthcare sector

High & Low

All-time High

$706.00 K
VTVT quarterly cash flow from operations is currently -1009.07% below its historical high of $706.00 thousand

3-Year Low

-$8.83 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTVT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
VTVT next earnings announcement is scheduled for Mar 13, 2025

OtherVTVTcash flowmetrics:

Quarterly CFI

-
VTVT quarterly cash flow from investing activities value is unknown

Quarterly CFF

$2.46 M
VTVT quarterly cash flow from financing activities is $2.46 million

Quarterly FCF

-$6.42 M
VTVT quarterly free cash flow is -$6.42 million

Quarterly CAPEX

-
VTVT quarterly capital expenditures value is unknown

TTM CFO

-$23.40 M
-$1.58 M-7.26%

September 30, 2024

Summary

Performance

3-Month Change

-7.26%

1-Year Change

-7.26%

3-Year Change

+13.48%

5-Year Change

-4.33%

VTVT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.1%
VTVT TTM cash flow from operations is higher than 42.1% of companies in Healthcare sector

High & Low

All-time High

-$10.33 M

3-Year Low

-$27.04 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTVT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
VTVT next earnings announcement is scheduled for Mar 13, 2025

OtherVTVTcash flowmetrics:

TTM CFI

-
VTVT TTM cash flow from investing activities value is unknown

TTM CFF

$52.33 M
VTVT TTM cash flow from financing activities is $52.33 million

TTM FCF

-$23.40 M
VTVT TTM free cash flow is -$23.40 million

TTM CAPEX

-
VTVT TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

VTVT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.1%+4.6%-7.3%
3 y3 years-6.0%-4.1%+13.5%
5 y5 years+28.9%-33.9%-4.3%

VTVT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-19.1%+1.2%-1009.1%+27.3%-126.6%+13.5%
5 y5-year-19.1%+17.1%-1009.1%+27.3%-126.6%+13.5%
alltimeall time-19.1%+60.4%-1009.1%+53.5%-126.6%+53.8%

VTv Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.42 M(-4.6%)
-$23.40 M(+7.3%)
Jun 2024
-
-$6.73 M(-8.3%)
-$21.81 M(+2.6%)
Mar 2024
-
-$7.33 M(+151.7%)
-$21.25 M(+11.4%)
Dec 2023
-$19.08 M(+19.1%)
-$2.91 M(-39.7%)
-$19.08 M(-17.2%)
Sep 2023
-
-$4.83 M(-21.6%)
-$23.05 M(-14.8%)
Jun 2023
-
-$6.17 M(+19.4%)
-$27.04 M(+34.1%)
Mar 2023
-
-$5.17 M(-24.9%)
-$20.17 M(+25.9%)
Dec 2022
-$16.02 M(-17.0%)
-$6.88 M(-22.1%)
-$16.02 M(+3.0%)
Sep 2022
-
-$8.83 M(-1350.3%)
-$15.56 M(+50.7%)
Jun 2022
-
$706.00 K(-169.1%)
-$10.33 M(-31.3%)
Mar 2022
-
-$1.02 M(-84.1%)
-$15.03 M(-22.2%)
Dec 2021
-$19.31 M(+7.3%)
-$6.42 M(+78.5%)
-$19.31 M(+27.8%)
Sep 2021
-
-$3.59 M(-10.1%)
-$15.10 M(-10.9%)
Jun 2021
-
-$4.00 M(-24.6%)
-$16.94 M(-4.5%)
Mar 2021
-
-$5.30 M(+139.6%)
-$17.74 M(-1.5%)
Dec 2020
-$18.00 M(-21.8%)
-$2.21 M(-59.3%)
-$18.00 M(-16.9%)
Sep 2020
-
-$5.43 M(+13.4%)
-$21.66 M(-3.4%)
Jun 2020
-
-$4.79 M(-13.8%)
-$22.43 M(-3.0%)
Mar 2020
-
-$5.56 M(-5.4%)
-$23.13 M(+0.5%)
Dec 2019
-$23.02 M
-$5.88 M(-5.1%)
-$23.02 M(+0.0%)
Sep 2019
-
-$6.20 M(+12.7%)
-$23.01 M(-0.3%)
Jun 2019
-
-$5.50 M(+0.9%)
-$23.08 M(-14.2%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$5.45 M(-7.1%)
-$26.91 M(+0.2%)
Dec 2018
-$26.86 M(-39.7%)
-$5.87 M(-6.2%)
-$26.86 M(-1.7%)
Sep 2018
-
-$6.26 M(-32.9%)
-$27.32 M(-16.8%)
Jun 2018
-
-$9.33 M(+72.9%)
-$32.83 M(-9.2%)
Mar 2018
-
-$5.40 M(-14.8%)
-$36.14 M(-18.9%)
Dec 2017
-$44.56 M(-7.6%)
-$6.33 M(-46.2%)
-$44.56 M(-10.3%)
Sep 2017
-
-$11.78 M(-6.8%)
-$49.66 M(-1.9%)
Jun 2017
-
-$12.64 M(-8.5%)
-$50.61 M(+2.2%)
Mar 2017
-
-$13.82 M(+20.9%)
-$49.52 M(+2.7%)
Dec 2016
-$48.21 M(+30.5%)
-$11.43 M(-10.2%)
-$48.21 M(+5.4%)
Sep 2016
-
-$12.73 M(+10.2%)
-$45.75 M(+6.8%)
Jun 2016
-
-$11.55 M(-7.6%)
-$42.85 M(+6.9%)
Mar 2016
-
-$12.50 M(+39.4%)
-$40.08 M(+8.5%)
Dec 2015
-$36.95 M(+20.0%)
-$8.97 M(-8.7%)
-$36.95 M(+5.7%)
Sep 2015
-
-$9.82 M(+11.8%)
-$34.95 M(+13.9%)
Jun 2015
-
-$8.79 M(-6.2%)
-$30.69 M(+5.3%)
Mar 2015
-
-$9.37 M(+34.2%)
-$29.15 M(-5.3%)
Dec 2014
-$30.78 M(-26.2%)
-$6.98 M(+25.6%)
-$30.78 M(+29.3%)
Sep 2014
-
-$5.56 M(-23.3%)
-$23.80 M(+30.5%)
Jun 2014
-
-$7.25 M(-34.1%)
-$18.24 M(+65.9%)
Mar 2014
-
-$11.00 M
-$11.00 M
Dec 2013
-$41.68 M
-
-

FAQ

  • What is vTv Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for vTv Therapeutics?
  • What is vTv Therapeutics annual CFO year-on-year change?
  • What is vTv Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for vTv Therapeutics?
  • What is vTv Therapeutics quarterly CFO year-on-year change?
  • What is vTv Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for vTv Therapeutics?
  • What is vTv Therapeutics TTM CFO year-on-year change?

What is vTv Therapeutics annual cash flow from operations?

The current annual CFO of VTVT is -$19.08 M

What is the all time high annual CFO for vTv Therapeutics?

vTv Therapeutics all-time high annual cash flow from operations is -$16.02 M

What is vTv Therapeutics annual CFO year-on-year change?

Over the past year, VTVT annual cash flow from operations has changed by -$3.06 M (-19.09%)

What is vTv Therapeutics quarterly cash flow from operations?

The current quarterly CFO of VTVT is -$6.42 M

What is the all time high quarterly CFO for vTv Therapeutics?

vTv Therapeutics all-time high quarterly cash flow from operations is $706.00 K

What is vTv Therapeutics quarterly CFO year-on-year change?

Over the past year, VTVT quarterly cash flow from operations has changed by +$311.00 K (+4.62%)

What is vTv Therapeutics TTM cash flow from operations?

The current TTM CFO of VTVT is -$23.40 M

What is the all time high TTM CFO for vTv Therapeutics?

vTv Therapeutics all-time high TTM cash flow from operations is -$10.33 M

What is vTv Therapeutics TTM CFO year-on-year change?

Over the past year, VTVT TTM cash flow from operations has changed by -$1.58 M (-7.26%)